首站-论文投稿智能助手
典型文献
Tumor necrosis factor-α signaling in nonalcoholic steatohepatitis and targeted therapies
文献摘要:
Nonalcoholic steatohepatitis(NASH),an inflammatory subtype of nonalcoholic fatty liver disease,is featured by significantly elevated levels of various proinflammatory cytokines.Among numerous proin-flammatory factors that contribute to NASH pathogenesis,the secreted protein,tumor necrosis factor-alpha(TNF-α),plays an essential role in multiple facets of NASH progression and is therefore considered as a potential therapeutic target.In this review,we will first systematically describe the preclinical studies on the biochemical function of TNF-α and its intracellular downstream signaling mechanisms through its re-ceptors.Moreover,we extensively discuss its functions in regulating inflammation,cell death,and fibrosis of liver cells in the pathogenesis of NASH,and the molecular mechanism that TNF-α expression is regulated by NF-κB and other upstream master regulators during NASH progression.As TNF-α is one of the causal factors that remarkably contributes to NASH progression,combination of therapeutic modalities,including TNF-α-based therapies may lead to the resolution of NASH via multiple pathways and thus generate clinical benefits.For translational studies,we summarize recent advances in strategies targeting TNF-α and its signaling pathway,which paves the way for potential therapeutic treatments for NASH in the future.
文献关键词:
作者姓名:
Sijia Lu;Yibing Wang;Junli Liu
作者机构:
Shanghai Diabetes Institute,Department of Endocrinology and Metabolism,Shanghai Jiao Tong University Affiliated Sixth People's Hospital,Shanghai 200233,China;School of Kinesiology,Shanghai University of Sports,Shanghai 200438,China
文献出处:
引用格式:
[1]Sijia Lu;Yibing Wang;Junli Liu-.Tumor necrosis factor-α signaling in nonalcoholic steatohepatitis and targeted therapies)[J].遗传学报,2022(04):269-278
A类:
ceptors
B类:
Tumor,necrosis,signaling,nonalcoholic,steatohepatitis,targeted,therapies,Nonalcoholic,NASH,subtype,fatty,liver,disease,featured,by,significantly,elevated,levels,various,proinflammatory,cytokines,Among,numerous,factors,that,pathogenesis,secreted,protein,tumor,alpha,plays,essential,role,multiple,facets,progression,therefore,considered,potential,therapeutic,In,this,review,we,will,first,systematically,describe,preclinical,studies,biochemical,intracellular,downstream,mechanisms,through,Moreover,extensively,discuss,functions,regulating,inflammation,death,fibrosis,cells,molecular,expression,regulated,other,upstream,master,regulators,during,one,causal,remarkably,contributes,combination,modalities,including,may,lead,resolution,via,pathways,thus,generate,benefits,For,translational,summarize,recent,advances,strategies,targeting,which,paves,treatments,future
AB值:
0.570783
相似文献
Globular adiponectin-mediated vascular remodeling by affecting the secretion of adventitial-derived tumor necrosis factor-αinduced by urotensin Ⅱ
Jun LI;Limin LUO;Yonggang ZHANG;Xiao DONG;Shuyi DANG;Xiaogang GUO;Wenhui DING-Department of Cardiology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Division of Cardiology,Department of Internal Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,China;Division of Cardiology,Department of Internal Medicine,Peking University First Hospital,Beijing 100034,China;Department of Dermatology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Cardiovascular Diseases,the Second Affiliated Hospital,Shantou University Medical College,Shantou 515041,China
EGFR signaling promotes nuclear translocation of plasma membrane protein TSPAN8 to enhance tumor progression via STAT3-mediated transcription
Xiaoqing Lu;Liwei An;Guangjian FanTi;Lijuan Zang;Weiyi Huang;Junjian Li;Jun Liu;Weiyu Ge;Yuwei Huang;Jingxuan Xu;Shaoqian Du;Yuan Cao;Tianhao Zhou;Huijing Yin;Li Yu;Shi Jiao;Hongxia Wang-State Key Laboratory of Oncogenes and Related Genes,Department of Oncology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;Department of Breast Surgery,Shanxi Cancer Hospital,Chinese Academy of Medical Sciences,Taiyuan,Shanxi,China;Department of Medical Ultrasound,Shanghai Tenth People's Hospital,Tongji University Cancer Center,School of Medicine,Tongji University,Shanghai,China;Precision Research Center for Refractory Diseases,Institute for Clinical Research,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;Department of Pathology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;State Key Laboratory of Membrane Biology,Tsinghua-Peking University Joint Center for Life Sciences,School of Life Science,Tsinghua University,Beijing,China;State Key Laboratory of Genetic Engineering,School of Life Sciences,Fudan University,Shanghai,China
CXCR6-based immunotherapy in autoimmune,cancer and inflammatory infliction
Tingting Li;Jie Pan;Hongqi Chen;Yongliang Fang;Yang Sun-Department of Gastroenterology,the Second Medical Center National Clinical Research Center for Geriatric Diseases,State Key Laboratory of Kidney Diseases,Chinese PLA General Hospital,Beijing 100853,China;State Key Laboratory of Pharmaceutical Biotechnology,Department of Biotechnology and Pharmaceutical Sciences,School of Life Sciences,Nanjing University,Nanjing 210023,China;Department of General Surgery,Shanghai Jiao Tong University Affiliated Sixth People's Hospital,Shanghai 200233,China;Department of Urology,Boston Children's Hospital,Departments of Microbiology and Surgery,Harvard Medical School,Boston,MA 02115,USA;Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy,Xuzhou Medical University,Xuzhou 221004,China
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
Yi-kuan Wu;Zheng-nan Ren;Sheng-long Zhu;Yun-zhou Wu;Gang Wang;Hao Zhang;Wei Chen;Zhao He;Xian-long Ye;Qi-xiao Zhai-State Key Laboratory of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Medicine,Jiangnan University,Wuxi 214122,China;College of Life Science,Northeast Agricultural University,Harbin 150038,China;National Engineering Research Center for Functional Food,Jiangnan University,Wuxi 214122,China;Shandong Key Laboratory of Endocrinology and Lipid Metabolism,Jinan 250021,China;School of Medicine,Shandong University,Jinan 250012,China;Ganjiang Chinese Medicine Innovation Center,Nanchang 330000,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。